DEN DANSKE FORSKNINGSFOND — Credit Rating and Financial Key Figures
CVR number: 16205036
Vedbæk Strandvej 350, 2950 Vedbæk
tn@nordicbio.com
tel: 44684220
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -1 324.18 | - 516.90 | -1 456.60 | - 627.98 | - 820.87 |
Employee benefit expenses | - 671.97 | - 799.70 | - 738.21 | -1 325.75 | -1 011.34 |
EBIT | -1 996.15 | -1 316.60 | -2 194.82 | -1 953.73 | -1 832.22 |
Other financial income | 76 179.72 | 72 444.90 | 166 356.37 | 2 456.99 | 921.56 |
Other financial expenses | -6 797.92 | -5 995.41 | -4 080.74 | - 151 952.14 | -21 313.55 |
Income from other inv. held as non-curr. assets | - 121 140.35 | - 500.00 | |||
Net income from associates (fin.) | -3 238.45 | -4 361.76 | -6 529.19 | -4 177.18 | -7 620.76 |
Pre-tax profit | 64 147.20 | 60 771.13 | 32 411.28 | - 156 126.05 | -29 844.97 |
Income taxes | - 686.65 | - 795.54 | - 904.70 | - 464.87 | -40.00 |
Net earnings | 63 460.55 | 59 975.58 | 31 506.58 | - 156 590.92 | -29 884.97 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 520.00 | 640.00 | 720.00 | 720.00 | 720.00 |
Tangible assets total | 520.00 | 640.00 | 720.00 | 720.00 | 720.00 |
Holdings in group member companies | 11 468.46 | 18 033.78 | 12 400.67 | 7 792.79 | 101.83 |
Investments total | 11 468.46 | 18 033.78 | 12 400.67 | 7 792.79 | 101.83 |
Non-curr. owed by group member comp. | 21 245.81 | ||||
Non-current loans receivable | 106 395.47 | 125 115.98 | 7 693.72 | 7 693.72 | 7 693.72 |
Long term receivables total | 106 395.47 | 125 115.98 | 7 693.72 | 7 693.72 | 28 939.53 |
Inventories total | |||||
Current amounts owed by group member comp. | 57.46 | ||||
Prepayments and accrued income | 6.38 | ||||
Current other receivables | 244.05 | 0.04 | |||
Current deferred tax assets | 259.48 | ||||
Short term receivables total | 259.48 | 301.51 | 0.04 | 6.38 | |
Other current investments | 238 292.43 | 259 912.82 | 401 164.07 | 217 161.77 | 149 933.73 |
Cash and bank deposits | 53 594.24 | 38 554.21 | 21 579.47 | 25 326.37 | 13 748.53 |
Cash and cash equivalents | 291 886.67 | 298 467.03 | 422 743.54 | 242 488.14 | 163 682.25 |
Balance sheet total (assets) | 410 530.08 | 442 558.30 | 443 557.93 | 258 694.70 | 193 449.99 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 5 500.00 | 5 500.00 | 5 500.00 | 5 500.00 | 5 500.00 |
Other reserves | - 264.53 | 500.90 | 70.20 | ||
Other restricted equity | 40 000.00 | 40 000.00 | 40 000.00 | 75 000.00 | 50 000.00 |
Retained earnings | 301 099.94 | 337 116.75 | 365 795.72 | 302 964.94 | 108 174.04 |
Profit of the financial year | 63 460.55 | 59 975.58 | 31 506.58 | - 156 590.92 | -29 884.97 |
Shareholders equity total | 410 060.49 | 442 327.81 | 443 303.20 | 226 944.22 | 133 789.07 |
Provisions | 95.15 | ||||
Non-current deferred tax liabilities | 10 300.00 | 25 900.00 | |||
Non-current liabilities total | 10 300.00 | 25 900.00 | |||
Current loans from credit institutions | 21 028.93 | 33 080.00 | |||
Current trade creditors | 218.78 | 61.90 | 130.88 | 237.50 | 343.03 |
Other non-interest bearing current liabilities | 155.67 | 168.60 | 123.85 | 184.05 | 337.90 |
Current liabilities total | 374.44 | 230.50 | 254.73 | 21 450.48 | 33 760.92 |
Balance sheet total (liabilities) | 410 530.08 | 442 558.30 | 443 557.93 | 258 694.70 | 193 449.99 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.